股票 › KLRA
凯莱拉治疗 KLRA
美股市值排名 #2856
$12.97 +$0.80 (+6.57%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $13.31 +2.62%
开盘$12.29
昨收$12.17
当日区间$11.97 – $13.26
成交量733.3K
市值$1.68B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例99.5%+0.09 个百分点，较上季度
持仓机构数128+7 ，较上季度
内部人近期交易23次买入 / 0次卖出净买入
空头持仓比例6.41% 占流通股回补天数 5.7 · 截至 15 Oct 2026
卖空成交量占比32.5%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：+$395.7K（10个净流入日，10个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有60.5%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从5.11%升至6.41%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Bain Capital, LP | VC/PE Fund | 2026/Q3 | +26,255,581 | 20.3% |
| Bain Capital Life Sciences Investors, LLC | VC/PE Fund | 2026/Q3 | +22,583,268 | 17.4% |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Public Company | 2026/Q3 | +11,511,852 | 8.9% |
| RTW Investments, LP | Hedge Fund | 2026/Q3 | +10,776,820 | 8.3% |
| Canada Pension Plan Investment Board | Government Pension Fund | 2026/Q3 | +7,304,688 | 5.6% |
| Atlas Venture Advisors, Inc. | VC/PE Fund | 2026/Q3 | +5,171,282 | 4.0% |
| FMR | Mutual Fund | 2026/Q3 | +3,970,865 | 3.1% |
| BlackRock | Mutual Fund | 2026/Q3 | +3,928,604 | 3.0% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +3,534,410 | 2.7% |
| Citadel Advisors LLC | Hedge Fund | 2026/Q3 | +3,240,787 | 2.5% |
| Adage Capital Management, L.P. | Hedge Fund | 2026/Q3 | +3,208,286 | 2.5% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +2,919,110 | 2.3% |
| RP Management, LLC | Private Company | 2026/Q3 | +2,455,357 | 1.9% |
| Artal Group S.A. | VC/PE Fund | 2026/Q3 | +2,214,286 | 1.7% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +1,984,086 | 1.5% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 6 Sep 2026 | Nur Nicholson | Other Derivative Acquisition | +220,000 | $16.23 | 220,000 | |
| 5 Jul 2026 | Kathleen Tregoning | Chief Corporate Affairs Officer | Other Derivative Acquisition | +175,000 | $23.30 | 175,000 |
| 8 Jun 2026 | Ronald Renaud | Chief Executive Officer | Derivative Exercise and Retained | +38,094 | $5.25 | 38,094 |
| 19 Apr 2026 | Bain Capital, LP | Private Acquisition | +8,398,438 | $16.00 | 26,255,581 | |
| 19 Apr 2026 | Bain Capital, LP | Derivative Exercise and Retained | +17,857,143 | – | 26,255,581 | |
| 19 Apr 2026 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Derivative Exercise and Retained | +11,511,852 | – | 11,511,853 | |
| 19 Apr 2026 | RTW Investments, LP | Private Acquisition | +500,000 | $16.00 | 10,776,820 | |
| 19 Apr 2026 | RTW Investments, LP | Derivative Exercise and Retained | +10,276,820 | – | 10,776,820 | |
| 19 Apr 2026 | Bain Capital Life Sciences Investors, LLC | Private Acquisition | +1,562,500 | $16.00 | 22,583,268 | |
| 19 Apr 2026 | Bain Capital Life Sciences Investors, LLC | Derivative Exercise and Retained | +21,020,768 | – | 22,583,268 | |
| 15 Apr 2026 | John Milligan | Independent Non-Employee Chairman | Other Derivative Acquisition | +38,300 | $16.00 | 38,300 |
| 15 Apr 2026 | John Milligan | Independent Non-Employee Chairman | Initial Statement of Beneficial | +0 | – | 599,124 |
| 15 Apr 2026 | Canada Pension Plan Investment Board | Initial Statement of Beneficial | +0 | – | 5,000,000 | |
| 15 Apr 2026 | Christopher Hite | Independent Director | Other Derivative Acquisition | +38,300 | $16.00 | 38,300 |
| 15 Apr 2026 | Christopher Hite | Independent Director | Initial Statement of Beneficial | +0 | – | 170,194 |
| 15 Apr 2026 | Jiangsu Hengrui Pharmaceuticals Co.,Ltd | Initial Statement of Beneficial | +0 | – | 1 | |
| 15 Apr 2026 | Ronald Renaud | Chief Executive Officer | Other Derivative Acquisition | +600,000 | $16.00 | 300,000 |
| 15 Apr 2026 | Ronald Renaud | Chief Executive Officer | Initial Statement of Beneficial | +0 | – | 3,918,467 |
| 15 Apr 2026 | Adam Koppel | Independent Director | Other Derivative Acquisition | +38,300 | $16.00 | 38,300 |
| 15 Apr 2026 | Martin MacKay | Independent Director | Other Derivative Acquisition | +38,300 | $16.00 | 38,300 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 8,316,466 | 6.4% | 5.7 |
| 30 Sep 2026 | 8,683,381 | 6.7% | 5.6 |
| 15 Sep 2026 | 5,962,752 | 4.6% | 7.6 |
| 31 Aug 2026 | 5,660,876 | 4.4% | 6.5 |
| 14 Aug 2026 | 6,065,081 | 4.7% | 20.1 |
| 31 Jul 2026 | 6,626,235 | 5.1% | 13.2 |
暂无评论——快来第一个聊聊 KLRA。
登录后参与讨论。